FIGURE 1.
Resistance of K562/FLM cells to flumatinib. (A) 72‐h cytotoxicity of flumatinib against K562 and K562/FLM cells. (B) Morphological observation of K562 and K562/FLM cells after treatment with flumatinib for 72 h.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.